When myocardial ischemia-hypoxia damage occurs, H-FABP is rapidly released into the bloodstream, making it a common early biomarker for myocardial injury in clinical practice (Ye et al., 2018; Moon et al., 2021). Here, FABP3 is linked to myocardial ischemia.